TrianglePUBLICATIONS · 18165643
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2008 Jan 1
- First author
- Garcia AA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Garcia AA
- type
- Author
- name
- Hirte H
- type
- Author
- name
- Fleming G
- type
- Author
- name
- Yang D
- type
- Author
- name
- Tsao-Wei DD
- type
- Author
- name
- Roman L
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Swenson S
- type
- Author
- name
- Markland F
- type
- Author
- name
- Gandara D
- type
- Author
- name
- Scudder S
- type
- Author
- name
- Morgan R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Garcia AA
- type
- Author
- name
- Hirte H
- type
- Author
- name
- Fleming G
- type
- Author
- name
- Yang D
- type
- Author
- name
- Tsao-Wei DD
- type
- Author
- name
- Roman L
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Swenson S
- type
- Author
- name
- Markland F
- type
- Author
- name
- Gandara D
- type
- Author
- name
- Scudder S
- type
- Author
- name
- Morgan R
- type
- Author
- bibliography ids
- nci-bib-15b3a474ebed35099f1aa240
- book metadata
- content sha256
- 514309bb952c2df9c67f82e8cbdab3080231c80303717a4d4bacdba5d201b221
- document type
- citation
- dois
- 10.1200/JCO.2007.12.1939
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18165643
- immutable id
- pubmed:18165643@514309bb952c2df9c67f82e8cbdab3080231c80303717a4d4bacdba5d201b221
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 76-82
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18165643
- provenance
- batch id
- 89a0f2206e11ca092d02
- provider
- NCBI PubMed ESummary
- record sha256
- ceb188a2d229be98ef3a62fe86d50adc92903e90f6740bce7dc6ac593ef8c8c3
- response sha256
- 7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
- retrieved at
- 2026-09-09T23:46:16.784581+00:00
- publication date
- display
- 2008 Jan 1
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
Preserved source evidence · Not medical advice